THOGF yields 4.62% · MRK yields 2.76%● Live data
📍 THOGF pulled ahead of the other in Year 1
Combined, THOGF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of THOGF + MRK for your $10,000?
Toho Gas Co., Ltd. engages in the gas, heating and cooling, and electricity supply businesses in Japan. It is also involved in the development, purchase, and sale of natural gas and other energy resources; production, transportation, and sale of high-pressure gases, including LNG, LPG, and liquefied carbon dioxide; sale of coke, tar, and crude oil products; and production and sale of chemical industrial products, such as methanol and plasticizers. In addition, the company produces and sells gas, air-conditioning, kitchen, and plumbing equipment, as well as home and gas appliances; sells paving materials, automobiles, daily sundries, and foodstuffs; designs, administers, and constructs civil engineering, construction, wiring, piping, and machinery projects; and designs, produces, and sells equipment for the prevention of air and water pollution, waste treatment, and soil reclamation projects. Further, it is involved in the buying and selling, leasing, and management of real estate; provision of data processing and related services; production, lease, and sale of computer hardware and software; security business; and sale and lease of security and disaster prevention equipment. Additionally, the company engages in the management of cooking and cultural classrooms, and sport facilities; restaurant and travel agent proxy business; general leasing and financing activities; non-life insurance agency and life insurance soliciting business; and survey, research, and consulting, as well as other businesses. Toho Gas Co., Ltd. was incorporated in 1922 and is headquartered in Nagoya, Japan.
Full THOGF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.